116 related articles for article (PubMed ID: 38911989)
1. FPR1, as a Potential Biomarker of Diagnosis and Infliximab Therapy Responses for Crohn's Disease, is Related to Disease Activity, Inflammation and Macrophage Polarization.
Ye C; Zhu S; Yuan J; Yuan X
J Inflamm Res; 2024; 17():3949-3966. PubMed ID: 38911989
[TBL] [Abstract][Full Text] [Related]
2. Constructing models for Crohn's disease diagnosis and prediction of infliximab non-response based on angiogenesis-related genes.
Zheng C; Chen X; Ke Y; Xu X; Wu C; Jiang L
Front Immunol; 2024; 15():1239496. PubMed ID: 38343536
[TBL] [Abstract][Full Text] [Related]
3. Hsa_circRNA_103124 upregulation in Crohn's disease promoted macrophage M1 polarization to maintain an inflammatory microenvironment via activation of the AKT2 and TLR4/NF-κB pathways.
Yin J; Hu T; Xu L; Zhang L; Zhu J; Ye Y; Pang Z
Int Immunopharmacol; 2023 Oct; 123():110763. PubMed ID: 37567009
[TBL] [Abstract][Full Text] [Related]
4. Formylated Peptide Receptor-1-Mediated Gut Inflammation as a Therapeutic Target in Inflammatory Bowel Disease.
McAllister MJ; Hall R; Whelan RJ; Fischer LJ; Chuah CS; Cartlidge PD; Drury B; Rutherford DG; Duffin RM; Cartwright JA; Dorward DA; Rossi AG; Ho GT
Crohns Colitis 360; 2024 Jan; 6(1):otae003. PubMed ID: 38352118
[TBL] [Abstract][Full Text] [Related]
5. Eriocalyxin B ameliorated Crohn's disease-like colitis by restricting M1 macrophage polarization through JAK2/STAT1 signalling.
Cheng Y; Li J; Wang L; Wu X; Li Y; Xu M; Li Q; Huang J; Zhao T; Yang Z; Zhang H; Zuo L; Zhang X; Geng Z; Wang Y; Song X; Zhang J
Eur J Pharmacol; 2023 Sep; 954():175876. PubMed ID: 37391008
[TBL] [Abstract][Full Text] [Related]
6.
Tang N; Yang Y; Xie Y; Yang G; Wang Q; Li C; Liu Z; Huang JA
Front Immunol; 2024; 15():1344805. PubMed ID: 38440722
[TBL] [Abstract][Full Text] [Related]
7. hUC-MSCs therapy for Crohn's disease: efficacy in TNBS-induced colitis in rats and pilot clinical study.
Sun Q; Li S; Lin R; Zhao G; Lu J; Liu B; Hu M; Wang W; Yang X; Wei Y; Jia W; Hu Y; Zhang W; Zhu J; Cui D; Zhong L
EBioMedicine; 2024 May; 103():105128. PubMed ID: 38653187
[TBL] [Abstract][Full Text] [Related]
8. Selective M1 macrophage polarization in granuloma-positive and granuloma-negative Crohn's disease, in comparison to intestinal tuberculosis.
Das P; Rampal R; Udinia S; Kumar T; Pilli S; Wari N; Ahmed IK; Kedia S; Gupta SD; Kumar D; Ahuja V
Intest Res; 2018 Jul; 16(3):426-435. PubMed ID: 30090042
[TBL] [Abstract][Full Text] [Related]
9. Sotetsuflavone ameliorates Crohn's disease-like colitis by inhibiting M1 macrophage-induced intestinal barrier damage via JNK and MAPK signalling.
Ge S; Yang Y; Zuo L; Song X; Wen H; Geng Z; He Y; Xu Z; Wu H; Shen M; Ge Y; Sun X
Eur J Pharmacol; 2023 Feb; 940():175464. PubMed ID: 36566007
[TBL] [Abstract][Full Text] [Related]
10. Integrated multiple microarray studies by robust rank aggregation to identify immune-associated biomarkers in Crohn's disease based on three machine learning methods.
Chen ZA; Ma HH; Wang Y; Tian H; Mi JW; Yao DM; Yang CJ
Sci Rep; 2023 Feb; 13(1):2694. PubMed ID: 36792688
[TBL] [Abstract][Full Text] [Related]
11. Crohn's disease-associated AIEC inhibiting intestinal epithelial cell-derived exosomal let-7b expression regulates macrophage polarization to exacerbate intestinal fibrosis.
Xu Y; Qian W; Huang L; Wen W; Li Y; Guo F; Zhu Z; Li Z; Gong J; Yu Z; Zhou Y; Lu N; Zhu W; Guo Z
Gut Microbes; 2023; 15(1):2193115. PubMed ID: 36945126
[TBL] [Abstract][Full Text] [Related]
12. Identification of Potential Genes and Critical Pathways in Postoperative Recurrence of Crohn's Disease by Machine Learning And WGCNA Network Analysis.
Rajalingam A; Sekar K; Ganjiwale A
Curr Genomics; 2023 Oct; 24(2):84-99. PubMed ID: 37994325
[TBL] [Abstract][Full Text] [Related]
13. Machine learning-based metabolism-related genes signature, single-cell RNA sequencing, and experimental validation in hypersensitivity pneumonitis.
He J; Wang B; Chen M; Song L; Li H
Medicine (Baltimore); 2023 Oct; 102(40):e34940. PubMed ID: 37800807
[TBL] [Abstract][Full Text] [Related]
14. Identification and validation of the common pathogenesis and hub biomarkers in Hirschsprung disease complicated with Crohn's disease.
Wang J; Li Z; Xiao J; Wu L; Chen K; Zhu T; Feng C; Zhuansun D; Meng X; Feng J
Front Immunol; 2022; 13():961217. PubMed ID: 36248794
[TBL] [Abstract][Full Text] [Related]
15. Identification of Key Disulfidptosis-Related Genes and Their Association with Gene Expression Subtypes in Crohn's Disease.
Fu M; Aihemaiti D; Fu H; Li N; Yuan Y; Ye M
J Inflamm Res; 2024; 17():3655-3670. PubMed ID: 38863903
[TBL] [Abstract][Full Text] [Related]
16. Integrating machine learning algorithms and single-cell analysis to identify gut microbiota-related macrophage biomarkers in atherosclerotic plaques.
Ke Y; Yue J; He J; Liu G
Front Cell Infect Microbiol; 2024; 14():1395716. PubMed ID: 38716195
[TBL] [Abstract][Full Text] [Related]
17. Crohn's Disease Patients with Depression Exhibit Alterations in Monocyte/Macrophage Phenotype and Increased Proinflammatory Cytokine Production.
Tang Y; Zhao L; Lei N; Chen P; Zhang Y
Dig Dis; 2020; 38(3):211-221. PubMed ID: 31216541
[TBL] [Abstract][Full Text] [Related]
18. Identification of immune infiltration and cuproptosis-related subgroups in Crohn's disease.
Yuan Y; Fu M; Li N; Ye M
Front Immunol; 2022; 13():1074271. PubMed ID: 36466876
[TBL] [Abstract][Full Text] [Related]
19. The CSF-1-receptor inhibitor, JNJ-40346527 (PRV-6527), reduced inflammatory macrophage recruitment to the intestinal mucosa and suppressed murine T cell mediated colitis.
Manthey CL; Moore BA; Chen Y; Loza MJ; Yao X; Liu H; Belkowski SM; Raymond-Parks H; Dunford PJ; Leon F; Towne JE; Plevy SE
PLoS One; 2019; 14(11):e0223918. PubMed ID: 31710624
[TBL] [Abstract][Full Text] [Related]
20. Adipose tissue-derived mesenchymal stem cells' acellular product extracellular vesicles as a potential therapy for Crohn's disease.
Altemus J; Dadgar N; Li Y; Lightner AL
J Cell Physiol; 2022 Jul; 237(7):3001-3011. PubMed ID: 35522572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
